(Q35005972)
Statements
Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and design (English)
Oliver Sartor
Leonard G Gomella
Paul Gagnier
Karen Melich